SYDNEY: #AI--Integrant today announced the formal publication of its proprietary “CTC Formula” in Chaos to Creation, (ISBN9798255688227) marking the first time the framework has been made accessible to the public, researchers, and the broader scientific community.

Professor Gordon Slater, author of the book said, “We have been working closely with AI and blended real world data with hypothesis to arrive at the formula”.

Developed over several years, the CTC Formula is grounded in ongoing research and serves as a central component of Integrant’s evolving scientific architecture. It reflects a systems-based approach to understanding the dynamic balance between regeneration and degeneration-an idea explored in depth in Chapter 9, Beyond Mortality: The Promise of Regenerative Medicine.

Positioned as a conceptual model rather than a single solution, the formula captures a unifying principle: functional lifespan is shaped by the interplay between biological repair, accumulated damage, and the body’s capacity to restore itself over time. This framework underpins much of Integrant’s research direction and long-term vision.

The CTC Formula also operates as the “Regenerative Matrix Engine” (RME) within Integrant’s AI-driven “Wassup” ecosystem, a deeply integrated platform designed to model biological systems, identify patterns, and support the development of future regenerative strategies. By embedding this Regenerative Matrix Engine within an adaptive AI environment, Integrant aims to refine how complex biological processes are analysed and understood at scale.

In a move intended to advance scientific dialogue, Integrant has authorised the inclusion of the formula in Chaos to Creation, enabling broader visibility and engagement beyond internal research settings. The company views this as a step toward fostering collaboration, encouraging scrutiny, and supporting the continued evolution of ideas within regenerative science.

Chaos to Creation explores the scientific, philosophical, and practical dimensions of ageing, longevity, and human potential. Through its discussion of regenerative principles, the book presents the perspective that ageing is not a fixed endpoint, but a process shaped by modifiable biological forces.

“Rather than presenting a definitive answer, the framework invites a more rigorous question,” the book notes. “What must consistently be true, over time, for the balance between degeneration and regeneration to shift?”

Integrant continues to advance its research and platform development as it moves toward its next phase of growth, including anticipated pre-IPO activities ahead of a proposed November 2026 listing.

About the book

The book is available for purchase through Amazon: https://www.amazon.com.au/Chaos-Creation-Prof-Gordon-Slater/dp/B0GWTQFMSP/ref=tmm_pap_swatch_0

About Integrant

Integrant is a biotechnology company focused on advancing regenerative science through integrated research, AI-driven systems, and novel biological frameworks. Its work centres on understanding and influencing the mechanisms underlying ageing, recovery, and human performance.

Fonte: Business Wire